This is in line with previous findings in our lab, where 53.3% (354/664) low primarily cytoplasmic PTPN2 expression was found in a large cohort consisting of women with low-risk post-menopausal breast cancer (Karlsson et al. 2018). The gene discussed is PTPN2; the disease is breast carcinoma.